Cellnovo Group announced that Javaid Masoud has been appointed as Chief Technology Officer effective immediately. Mr. Masoud has a proven track record of bringing new medical technologies from concept to product release with a system perspective. Working in the US and Europe, he is recognized for his consistent results and effective leadership in technology and product development by leading multi-functional international teams. Mr. Masoud was previously Senior Director of Patient Management System R&D at Sorin Group where he led the international hardware and software product development teams.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2019 | Cellnovo Group Stops Manufacturing and Commercial Operations | CI |
2019 | Cellnovo Group Sa Provides Revenue Guidance for the First Quarter of 2019 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.68M | |
-10.10% | 24.98B | |
+17.72% | 22.52B | |
-2.37% | 2.34B | |
+103.70% | 2.08B | |
-13.77% | 2.07B | |
-39.25% | 1.77B | |
-16.25% | 1.3B | |
+1.80% | 1.28B | |
-2.04% | 1.25B |
- Stock Market
- Equities
- CLNV Stock
- News Cellnovo
- Cellnovo Group Appoints Javaid Masoud as Chief Technology Officer